AngioDynamics (NSDQ:ANGO) shares are up a tad today after the medical device company beat Wall Street’s expectations with its fiscal 2nd-quarter earnings.
MassDevice Earnings Roundup
Layoffs ahead as Urologix restructures
Biomet swings to Q2 black
Biomet posted fiscal 2nd-quarter profits today, reporting sales growth for its core hip and knee replacement products and gains across the board for its other medical device lines.
The news augurs well for other orthopedic device makers, as Biomet’s early quarterly reports are seen on Wall Street as bellwethers for the rest of the industry.
Analogic’s shares flop as equipment delays sink Q1
Elekta slides on H1 profit decline
Orthofix gets Nasdaq delisting warninga amid delayed earnings
Sirona closes fiscal year 2013 lower than expected
Sirona Dental Systems (NSDQ:SIRO) reported its FY 2013 4th quarter and its full year’s earnings, where it took a hit, according to Wall Street estimates.
Cyberonics soars on a strong Q2 results, record sales, boosted guidance
Cyberonics (NSDQ:CYBX) saw some significant interest from Wall Street today after posting record sales for its 2nd quarter and increasing its projections for the rest of the year.
Listen to Cyberonics’ Q2 2014 earnings call
Milestone Scientific raises another $1.5M, releases Q3 earnings
Milestone Scientific (OTC:MLSS) said its subsidiary, Milestone Medical, sold $1.5 million of stock to European investors, bringing its total European fundraising efforts to $3 million.
Bovie Medical records more red in Q3
Bovie Medical (NYSE:BVX) reported its earnings for the 3rd quarter, where it took a hit in both lower sales and widening losses.
Bovie Medical posted losses of $341,000, or -2¢ per share, on sales of $5.8 million for the 3 months ended Sept. 30. Losses jumped nearly 5000% on a sales decrease of 13.2% compared with the same period last year.